US HR484 | 2021-2022 | 117th Congress

Status

Spectrum: Partisan Bill (Republican 24-0)
Status: Introduced on June 17 2021 - 25% progression, died in committee
Action: 2022-11-01 - Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Pending: House Subcommittee on Courts, Intellectual Property, And The Internet Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.

Sponsors


History

DateChamberAction
2022-11-01HouseReferred to the Subcommittee on Courts, Intellectual Property, and the Internet.
2021-06-17HouseReferred to the House Committee on the Judiciary.
2021-06-17HouseIntroduced in House

Subjects


US Congress State Sources


Bill Comments

feedback